Information and Communications Technology and Policy

Information and Communications Technology and Policy

Information and Communications Technology and Policy ›› 2024, Vol. 50 ›› Issue (3): 79-82.doi: 10.12267/j.issn.2096-5931.2024.03.012

Previous Articles     Next Articles

Bottlenecks of digital transformation in China’s biopharmaceutical industry and corresponding suggestions

WANG Xiaoling   

  1. Informatization and Industrialization Integration Research Institute, China Academy of Information and Communications Technology, Beijing 100191, China
  • Received:2023-09-26 Online:2024-03-25 Published:2024-03-29

Abstract:

As an emerging emerging industry in China, the biopharmaceutical industry is facing difficulties both internally and externally. Digital transformation has become a necessary path for overcoming adversities. However, the digital transformation of the biopharmaceutical industry is currently constrained by four major bottlenecks: insufficient data foundation, relatively lagging policy regulation, lack of targeted evaluation systems, and shortage of compound talents. The progress of transformation is relatively backward. It is recommended to accelerate the digital transformation of the biopharmaceutical industry by unifying data standards, establishing public data resource systems, innovating regulatory models, constructing transformation evaluation systems, and cultivating talent teams.

Key words: digital transformation, biopharmaceutical industry, pharmacy, bottleneck, suggestion

CLC Number: